Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeMARKET REPORTSArterial Blood Gas Kits Market Forecast to 2028: Research & Markets

Arterial Blood Gas Kits Market Forecast to 2028: Research & Markets

“Arterial Blood Gas Kits Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Product Type (1mL (Syringe Volume), 3mL (Syringe Volume), and Others); End User (Hospitals, Clinics, and Others), and Geography” report has been added to ResearchAndMarkets.com’s offering.

Growing Geriatric Population Likely to Gain Traction in Arterial Blood Gas Kits Market During 2020-2028

Arterial Blood Gas Kits Market is expected to reach US$ 773.01 million in 2028 from US$ 455.84 million in 2021 growing at a CAGR of 7.8% from 2021-2028.

The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.

Becton Dickinson and Company, Radiometer Medical ApS, Smiths Medical, Vyaire Medical, Opti Medical Systems, Inc., Westmed Medical, Siemens Healthineers AG, ITL Biomedical, i-SENS, Inc., and Teleflex Incorporated amongst others are the leading companies operating in the micro catheters and micro guidewires market.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Arterial Blood Gas Kits market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global Arterial Blood Gas Kits market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Key Topics Covered:

1. Introduction

2. Arterial Blood Gas Kits Market – Key Takeaways

3. Research Methodology

4. Global Arterial Blood Gas Kits Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Expert Opinions

5. Arterial Blood Gas Kits Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Respiratory Diseases

5.1.2 Growing Prevalence of Metabolic and Kidney Diseases

5.2 Market Restraints

5.2.1 Risks, Complications, and Sampling Errors Associated with Arterial Blood Sampling

5.3 Market Opportunities

5.3.1 Growing Geriatric Population

5.4 Future Trends

5.4.1 Strategic Developments by Manufacturers

5.5 Impact Analysis

6. Arterial Blood Gas Kits Market – Global Analysis

6.1 Global Arterial Blood Gas Kits Market Revenue Forecast and Analysis

6.2 Global Arterial Blood Gas Kits Market, By Geography – Forecast and Analysis

6.3 Market Positioning of Key Players

7. Arterial Blood Gas Kits Market Analysis By Product

7.1 Overview

7.2 Arterial Blood Gas Kits Market Revenue Share, by Product (2021 and 2028)

7.3 1ml (Syringe Volume)

7.4 3ml (Syringe Volume)

8. Arterial Blood Gas Kits Market – By End User

8.1 Overview

8.2 Arterial Blood Gas Kits Market Revenue Share, by End User (2021 and 2028)

8.3 Hospitals

8.4 Clinics

9. Arterial Blood Gas Kits Market – Geographic Analysis

9.1 Arterial Blood Gas Kits Market – Revenue and Forecast to 2028 (USD Million)

9.2 Arterial Blood Gas Kits Market, by Product – Revenue and Forecast to 2028 (USD Million)

9.3.Arterial Blood Gas Kits Market, by End User – Revenue and Forecast to 2028 (USD Million)

9.4 Arterial Blood Gas Kits Market, by Country, 2021& 2028 (%)

10. Impact of COVID-19 Pandemic on Global Arterial Blood Gas Kits Market

11. Arterial Blood Gas Kits Market-Industry Landscape

11.1 Overview

11.2 Growth Strategies Done by the Companies in the Market, (%)

11.3 Organic Developments

11.4 Inorganic Developments

12. Company Profiles

  • Becton Dickinson and Company
  • Radiometer Company
  • Smiths Medical
  • Vyaire Medical
  • OPTI Medical
  • Westmed Medical
  • CareFusion(Cardinal Health)
  • Fisher Scientific
  • ITL BioMedical
  • Typenex Medical, LLC

For more information about this report visit https://www.researchandmarkets.com/r/v4t7ec

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy